Indianapolis-based TriMedx, which provides clinical asset management and clinical engineering services, announced that it has completed the acquisition of Aramark’s Healthcare Technologies (HCT) business.
“The successful completion of this acquisition is an important milestone in our strategic growth,” says Henry Hummel, CEO of TriMedx. “We are excited to continue to lead the transformation of the industry by expanding our proprietary technology-driven solutions to a broader set of healthcare provider customers, driving clinical and financial results, as well as device security and compliance, with measurable and persistent value in an ever-changing environment.”
HCT President Kristi McDermott also spoke out about the acquired business, which has been renamed TMX Healthcare Technologies. “We are excited to be part of an organization focused exclusively on delivering best-in-class clinical asset management services,” McDermott says. “Both organizations share core values of innovation and improving the health and lives of our associates, our customers, and those in our communities.”
The finalization of the acquisition comes roughly two months after TriMedx announced that it had entered into a definitive agreement to acquire Aramark’s HCT business, which provided healthcare technology services—ranging from repair and maintenance to the outsourcing of clinical engineering services—to more than 500 healthcare providers nationwide.
At the time, company officials remarked that the acquisition of Aramark HCT allows TriMedx to deliver its proprietary, technology-driven solutions to a broader set of healthcare provider customers, driving clinical and financial results, as well as device security and compliance.
This is encouraging news! This acquisition by the best in the business will certainly bring about good things forthe HTM industry. Congratulations to TMX Healthcare!
Question: If I recall the TrimedX acquisition of Aramark was requiring regulatory approvals from a potential anti-trust issue, i.e. controlling more than 40% market share.
Any updates on this matter? Thanks.